Nsaid

NSAIDs “provide the greatest benefit and least harm” for treating acute pain in children compared with ketamine and opioids, according to findings from a systematic review and meta-analysis published in JAMA Pediatrics.

In the third episode of the NSAIDs saga, we focus on COX-2 inhibition! Did the hopes and dreams of selective COX-2 inhibition pan out? What can the rise and fall of VIOXX teach us about physiology?

SAN ANTONIO — With a little patience, physicians can challenge and delabel NSAID hypersensitivity in the office, David A. Khan, MD, said during the 16th Annual Allergy, Asthma & Immunology CME Conference.

Researchers estimated that nearly 15.6 million Americans consumed at least one potentially hepatotoxic botanical product in the past 30 days, similar to usage reports for simvastatin and NSAIDS.

In this episode, we dive into the story of aspirin and the development of ibuprofen, ending with the experiments that showed the mechanism of how aspirin actually works.

Humans have had an insatiable appetite for inhibiting production of prostaglandins for centuries! This series delves into the history of aspirin and NSAIDs, looking at the understanding of the prostaglandin pathway.

At OSN New York 2023, Eric D. Donnenfeld, MD, and a panel of corneal experts assembled to discuss hot topics such as NSAID use after cataract surgery and dropless regimens.

For patients with diseases such as lupus or rheumatoid arthritis who take low-dose drugs at lower frequencies, the relief afforded by over-the-counter drugs such as ibuprofen and naproxen can be a boon.

Multiple risk factors were associated with NSAID-exacerbated respiratory disease, which itself is associated with uncontrolled or severe asthma, according to a study published in Clinical and Translational Allergy.

AUSTIN, Texas — Providers should carefully consider the “lipid paradox” when monitoring cardiovascular risks in patients with rheumatic inflammatory diseases, noted a presenter at the 2023 Rheumatology Nurses Society annual conference.